Clinical Trial Conduct Assistance

Keep your therapeutic development on track, even in our ever-changing landscape 

Advancing clinical trials through phase I-III is more complex and challenging than ever due to the ongoing COVID-19 pandemic.  At its onset, the outbreak quickly halted or delayed countless clinical trials, some of which are just beginning to restart now.  Additionally, COVID-19 restrictions have forced drug developers to rapidly change their approaches to conducting trials primarily by adopting virtual elements.  All these changes are decelerating the speed of clinical trials.

 

Our clinical trial support team understands that clinical trial delays can be catastrophic to you, your therapeutic. To give you an advantage Veristat has assembled a team of scientific-minded experts adept at driving trials forward even if it means pivoting to overcome challenges along the way. ​ 

 Adapting to Rapidly Changing Clinical Trial Norms

  • Trial design modifications due to changing regulatory guidance in response to COVID-19
  • Dynamically changing physical site access restrictions
  • Adoption of virtual technologies such as telemedicine, eConsent, eSource, etc.
  • Slower than normal patient recruitment
  • Introduction of at-home patient visits, local labs
  • Mitigation of data gaps due to a growing trend of earlier patient withdrawal
  • Revising statistical analysis plans due to changing patient populations
  • Deploying newer site models, such as central site model, hybrid site models (mix of on-site and remote), and fully remote site models

These trends continue to change as local conditions shift. Our teams, overseen by our COVID 19 Taskforce, are sharing lessons learned and rapidly adapting to these shifting conditions for running COVID-19 and non-COVID-19 trials in the current landscape.
Veristat_icon_experience-216

Expertise From

600+ Rare Disease Trials

550+ Oncology Trials

250+ Infectious Disease Trials

100+ Cell/Gene Therapy Trials

30+ COVID-19 Trials

Adapting to Rapidly Changing Clinical Trial Norms

  • Trial design modifications due to changing regulatory guidance in response to COVID-19
  • Dynamically changing physical site access restrictions
  • Adoption of virtual technologies such as telemedicine, eConsent, eSource, etc.
  • Slower than normal patient recruitment
  • Introduction of at-home patient visits, local labs

 
  • Mitigation of data gaps due to a growing trend of earlier patient withdrawal
  • Revising statistical analysis plans due to changing patient populations
  • Deploying newer site models, such as central site model, hybrid site models (mix of on-site and remote), and fully remote site models

These trends continue to change as local conditions shift. Our teams, overseen by our COVID 19 Taskforce, are sharing lessons learned and rapidly adapting to these shifting conditions for running COVID-19 and non-COVID-19 trials in the current landscape.

Essential Support During Clinical Trial Conduct

Operationalizing a clinical development plan is highly complex, unique, and requires close collaboration between an interdisciplinary team of regulatory, clinical, medical, statistical, data, safety, and scientific experts. Our teams ensure that the processes are in place to advance through phase I, II, and III trials, even when planned or unexpected challenges arise.

 
Phase I, II and III Clinical Trial Operations
  
Clinical, Medical & Project Management Teams
   
Data and Statistical Teams
   
Regulatory & Medical Writing Teams
  
Monitor and support the clinical trial sites with training,
   
Build, test, and deploy clinical trial database(s)
   
Informed Consent Forms
  
Manage the study timeline, risk mitigation, and overcome the challenges that arise
   
Perform training for site data collection
   
Clinical Study Reports (CSRs)
  
Provide safety management and reporting throughout trial 
   
Rapid data cleaning for data review committees or interim analyses
   
Safety Narratives

 


The Right Resources to Conduct Clinical Trials

With Veristat, you get the right resources to run your phase I, II and III clinical trials in the rapidly changing environment today. We are ready and equipped to help you solve all the challenges that arise as you try to keep your programs on track.  When you work with Veristat, you get:

  • A scientific-minded partner to navigate the unpredictable​, with regulatory, medical, and statistical insights
  • Quick adaptation of programs not performing
  • Learnings from other therapeutic development programs​
  • Confidence in patient safety, your clinical trial data, and accuracy of your endpoints​
  • An agile plan from first patient in through database lock 

 

More Clinical Trial Conduct Support

Learn more about our specific clinical trial conduct services to keep your trial on track. ​

 

Let's Talk. Get the right resources to keep your trial moving forward now.
Contact Us Today!

LET'S TALK
Request A Proposal
  • Privacy Policy
  • ©2006 - 2021 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.